Dose-related effect of intranasal corticosteroids on treatment outcome of persistent allergic rhinitis

Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 4, 2008, Pages 565-569

  Kirtsreesakul, Virat ^a   Chansaksung, Prichaya ^a   Ruttanaphol, Suwalee ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PEAK EXPIRATORY FLOW; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 52349114648     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.07.023     Document Type: Article

References (24)

1. Keslin N.H., Jarrell C.M., and Gregory C. Diagnosis and treatment of allergic rhinitis: primary care in an integrated health system setting. Am J Manag Care 5 (1999) 248-256
2. Canonica G.W., Holgate S.T., Karlsson G., et al. The impact of allergic rhinitis on quality of life and other airway diseases-summary of a European conference. Allergy 53 (1998) 7-31
3. Pumhirun P., Towiwat P., and Mahakit P. Aeroallergen sensitivity of Thai patients with allergic rhinitis. Asian Pac J Allergy Immunol 15 (1997) 183-185
4. Bousquet J., Van Cauwenberge P., Khaltaev N., et al. Allergic rhinitis and its impact on asthma (ARIA) (ARIA Workshop Report). J Allergy Clin Immunol 108 suppl 5 (2001) 147-334
5. Loh C.Y., Chao S.S., Chan Y.H., et al. A clinical survey on compliance in the treatment of rhinitis using nasal steroids. Allergy 59 (2004) 1168-1172
6. Juniper E.F., Guyatt G.H., O'Byrne P.M., et al. Aqueous beclomethasone dipropionate nasal spray: regular versus "as required" use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 86 (1990) 380-386
7. Juniper E.F., Guyatt G.H., Archer B., et al. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use. J Allergy Clin Immunol 92 (1993) 66-72
8. Nathan R.A., Eccles R., Howarth P.H., et al. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 115 (2005) S442-S459
9. Ahman M., and Soderman E. Serial nasal peak expiratory flow measurements in woodwork teachers. Int Arch Occup Environ Health 68 (1996) 177-182
10. Lildholdt T., Rundcrantz H., and Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 20 (1995) 26-30
11. Larsen K., Oxhoj H., Grontved A., et al. Peak flow nasal patency indices in patients operated for nasal obstruction. Eur Arch Otorhinolaryngol 248 (1990) 21-24
12. Ahman M. Nasal peak flow rate records in work related nasal blockage. Acta Otolaryngol 112 (1992) 839-844
13. Emberlin J.C., and Lewis R.A. A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin 23 (2007) 2423-2431
14. Frolund L., Madsen F., Mygind N., et al. Comparison between different techniques for measuring nasal patency in a group of unselected patients. Acta Otolaryngol 104 (1987) 175-179
15. Wihl J.A., and Malm L. Rhinomanometry and nasal peak expiratory and inspiratory flow rate. Ann Allergy 61 (1988) 50-55
16. Taylor G., Macneil A.R., and Freed D.L. Assessing degree of nasal patency by measuring peak expiratory flow rate through the nose. J Allergy Clin Immunol 52 (1973) 193-198
17. Phagoo S.B., Watson R.A., and Pride N.B. Use of nasal peak flow to assess nasal patency. Allergy 52 (1997) 901-908
18. Oluwole M., Gardiner Q., and White P.S. The naso-oral index: a more valid measure than peak flow rate?. Clin Otolaryngol Allied Sci 22 (1997) 346-349
19. Waddell A.N., Patel S.K., Toma A.G., et al. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?. J Laryngol Otol 117 (2003) 843-845
20. Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol 21 (2007) 70-79
21. Kobayashi R.H., Beaucher W.N., Koepke J.W., et al. Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 17 (1995) 503-513
22. Anderson M., Anderson P., and Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 82 (1998) 1019-1026
23. Dykewicz M.S., Kaiser H.B., Nathan R.A., et al. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Ann Allergy Asthma Immunol 91 (2003) 44-48
24. Day J.H., Buckeridge D.L., Clark R.H., et al. A randomized, double blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. J Allergy Clin Immunol 47 (1996) 118-125